Ribociclib for the treatment of hormone receptor-positive refractory advanced breast cancer: Managed access programme in Turkey


Demirci U., GÖKMEN E., Eralp Y. , Gunduz S., Goksu S. S. , KORKMAZ T. , ...More

San Antonio Breast Cancer Symposium, San-Antonio, Northern Mariana Islands, 10 - 14 December 2019, vol.80 identifier